OP75 Pharmaceutical Innovativeness Index: Evaluation Of Pharmaceutical Innovation In Lung Cancer Treatment Drugs Approved Between 2011 And 2021

IntroductionLung cancer (LC) ranks second globally in neoplasia diagnoses and exhibits the highest oncological mortality rate. Oncology has seen a marked increase in U.S. Food and Drug Administration (FDA) approvals for novel drugs, notably in the case of LC. This study aims to assess the innovative...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of technology assessment in health care 2025-01, Vol.40 (S1), p.S33-S33
Hauptverfasser:	Freitas, Isabela, Gargano, Ludmila, André, Ariane, de Assis Acurcio, Francisco, Alvares-Teodoro, Juliana, Guerra, Augusto
Format:	Artikel
Sprache:	eng
Schlagworte:	Alternatives Cancer therapies Clinical trials Decision making Drug development Drugs FDA approval Health care Health services Innovations Lung cancer Medical innovations Oral Presentations Pharmaceuticals Quality assessment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!